GARY I WEINGARDEN

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease RICHARDSON, TX NPI 1477501724

General Payments — all program years on this page

$3,832.63

  • Category: General Payments
  • Program years: PY2018–2022
  • Record count: 149
  • As of (CMS publication): 2026-01-23

Latest program year (PY2022): $408.97 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2022) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $408.9721

By paying entity

Latest program year (PY2022) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $1,474.6734
2019 $823.2941
2020 $544.6421
2021 $581.0632
2022 $408.9721

Records — PY2022 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
886944305 Janssen Pharmaceuticals, Inc $20.00 08/12/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
886944307 Janssen Pharmaceuticals, Inc $18.00 04/22/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
887398775 Boehringer Ingelheim Pharmaceuticals, Inc. $20.52 03/17/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
887541305 Boehringer Ingelheim Pharmaceuticals, Inc. $24.85 05/03/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
887541307 Boehringer Ingelheim Pharmaceuticals, Inc. $21.76 01/20/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
894445849 Novartis Pharmaceuticals Corporation $16.35 03/30/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
894445851 Novartis Pharmaceuticals Corporation $15.82 04/26/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
894445853 Novartis Pharmaceuticals Corporation $18.54 06/07/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
894445855 Novartis Pharmaceuticals Corporation $13.64 07/11/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
894445857 Novartis Pharmaceuticals Corporation $12.80 08/30/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
894445859 Novartis Pharmaceuticals Corporation $17.49 11/01/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
915423899 AstraZeneca Pharmaceuticals LP $16.02 03/31/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
920478273 Abbott Laboratories $34.12 05/02/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
939263511 Amgen Inc. $12.17 03/03/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
939263513 Amgen Inc. $16.60 09/06/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
939263515 Amgen Inc. $24.54 10/03/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
943841715 Edwards Lifesciences Corporation $17.53 02/02/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
944327081 Merck Sharp & Dohme LLC $14.20 01/26/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
947289987 Esperion Therapeutics, Inc. $17.69 03/28/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
949063675 PFIZER INC. $26.71 02/17/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
949128525 PFIZER INC. $29.62 05/11/2022 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.